::INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES::

CODEN : IAJPBB
issn 2349-7750

News Updates Latest Volumes: COSMOS IMPACT FACTOR (2018)- 4.153, GLOBAL IMPACT FACTOR(2014) - 0.384, (2015) - 0.437, Indo American Journal of Pharmaceutical Sciences,

ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

TITLE:

STUDY TO KNOW THE DYSLIPIDEMIA IN PATIENTS OF CHRONIC LIVER DISEASE

AUTHORS:

Dr. Kashaf Iqbal, Dr. Ayesha Kazlaq, Dr. Maria Akram

ABSTRACT:

Objective: To determine the changes in lipids metabolism in chronic liver disease patients. Study Design: Prospective, noninvasive observational study. Place and Duration: In the West Medical Department Mayo Hospital, Lahore for one year duration from September 2017 to September 2018. Methods: 160 patients who were admitted to the medical unit with the chronic liver disease diagnosis were selected for the analysis. In all cases, fasting lipid profile was done. The results were studied and compiled. Results: 63.75% patients were male and female and female were 58 (36.25%). Total cholesterol was significantly reduced in (15%) 24 patients. In the normal range, 132 patents were available (82.5%). Hypercholesterolemia was observed in 4 patients (2.5%). Hypertriglyceridemia was observed in one patient. The serum triglyceride level was lower in (63.13%) 101 cases. In all subjects HDL-c was lower than normal. LDL was found to be low in (88.13%) 141 patients, 12 (7.50%) patients has normal value and higher in (4.38%)7 subjects. Conclusion: In chronic liver disease, a common finding was dyslipidemia. With advanced liver disease, lipid profile should be performed in all subjects.